BIOGEN INC. Quarterly Costs and Expenses in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Biogen Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q2 2024.
  • Biogen Inc. Costs and Expenses for the quarter ending June 30, 2024 was $1.77B, a 1.05% increase year-over-year.
  • Biogen Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $8.36B, a 22% increase year-over-year.
  • Biogen Inc. annual Costs and Expenses for 2023 was $8.54B, a 29.7% increase from 2022.
  • Biogen Inc. annual Costs and Expenses for 2022 was $6.58B, a 28.7% decline from 2021.
  • Biogen Inc. annual Costs and Expenses for 2021 was $9.24B, a 10% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.36B $1.77B +$18.3M +1.05% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $8.34B $1.83B -$199M -9.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $8.54B $2.09B +$155M +7.96% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $8.38B $2.67B +$1.53B +135% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.85B $1.75B +$428M +32.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $6.42B $2.02B -$160M -7.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $6.58B $1.94B -$896M -31.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $7.48B $1.14B -$1.35B -54.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $8.83B $1.32B -$873M -39.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $9.7B $2.18B +$464M +27% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $9.24B $2.84B +$150M +5.58% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $9.09B $2.49B +$198M +8.65% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $8.89B $2.19B +$486M +28.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $8.4B $1.72B +$5.7M +0.33% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $8.4B $2.69B +$792M +41.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $7.6B $2.29B +$496M +27.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $7.11B $1.71B +$46.3M +2.79% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $7.06B $1.71B -$273M -13.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $7.34B $1.89B -$190M -9.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $7.52B $1.79B +$52.4M +3.01% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $7.47B $1.66B -$483M -22.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $7.96B $1.99B +$391M +24.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $7.56B $2.08B +$242M +13.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $7.32B $1.74B +$318M +22.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $7B $2.14B +$266M +14.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $6.74B $1.6B -$190M -10.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $6.93B $1.84B -$144M -7.24% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q3 2017 $7.07B $1.42B -$107M -6.97% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-23
Q2 2017 $7.18B $1.88B +$444M +30.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-24
Q1 2017 $6.73B $1.79B +$438M +32.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 $6.3B $1.98B +$313M +18.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q3 2016 $5.98B $1.53B +$125M +8.86% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 $5.86B $1.43B +$75.2M +5.54% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-25
Q1 2016 $5.78B $1.35B -$88.7M -6.17% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-25
Q4 2015 $5.87B $1.67B +$186M +12.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q3 2015 $5.69B $1.41B +$42.8M +3.14% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 $5.64B $1.36B -$78.1M -5.44% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-21
Q1 2015 $5.72B $1.44B -$25.2M -1.72% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-21
Q4 2014 $5.75B $1.49B +$170M +12.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q3 2014 $5.58B $1.36B +$213M +18.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-21
Q2 2014 $5.36B $1.44B +$370M +34.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
Q1 2014 $4.99B $1.46B +$553M +60.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-24
Q4 2013 $4.44B $1.32B +$328M +33.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q3 2013 $4.11B $1.15B +$268M +30.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-22
Q2 2013 $3.85B $1.07B +$151M +16.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-23
Q1 2013 $3.69B $910M -$13M -1.41% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-23
Q4 2012 $3.71B $988M +$69.9M +7.62% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q3 2012 $3.64B $882M +$60.6M +7.38% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $3.58B $915M +$117M +14.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $3.46B $923M +$136M +17.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $3.32B $918M +$53.7M +6.22% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q3 2011 $3.27B $821M -$160M -16.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $3.43B $798M -$19M -2.33% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-24
Q1 2011 $3.45B $787M -$18.1M -2.25% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q4 2010 $3.47B $864M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q3 2010 $982M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $817M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
Q1 2010 $805M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.